成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天

Cyclobutanemethanamine, 3-phenyl-, hydrochloride (1:1)

Cyclobutanemethanamine, 3-phenyl-, hydrochloride (1:1) Struktur
1803611-35-9
CAS-Nr.
1803611-35-9
Englisch Name:
Cyclobutanemethanamine, 3-phenyl-, hydrochloride (1:1)
Synonyma:
(3-phenylcyclobutyl)methanamine hydrochloride;1-(3-phenylcyclobutyl)methanamine hydrochloride;Cyclobutanemethanamine, 3-phenyl-, hydrochloride (1:1)
CBNumber:
CB45495056
Summenformel:
C11H16ClN
Molgewicht:
197.71
MOL-Datei:
1803611-35-9.mol

Cyclobutanemethanamine, 3-phenyl-, hydrochloride (1:1) Eigenschaften

Sicherheit

Cyclobutanemethanamine, 3-phenyl-, hydrochloride (1:1) Chemische Eigenschaften,Einsatz,Produktion Methoden

Cyclobutanemethanamine, 3-phenyl-, hydrochloride (1:1) Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

Cyclobutanemethanamine, 3-phenyl-, hydrochloride (1:1) Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.

Global( 8)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
Finetech Industry Limited 		+86-27-87465837 +8618971612321
 info@finetechnology-ind.com China 9640 58
Aladdin Scientific 		+1-+1(833)-552-7181
sales@aladdinsci.com United States 52925 58
Suzhou ARTK Medchem Co., Ltd. 		+86-512-68323658 +86-18168183658
 sales1@artkmedchem.com China 39004 58
Finetech Industry Limited 027-87465837 19945049750
 sales@finetechnology-ind.com China 9649 58
Beijing xinyanhui pharmaceutical research and development co., LTD 13969155946
 1461866103@qq.com China 16111 58
Block Chemical Technology (Shanghai) Co., Ltd. 021-20432219 13918097649
 li_jinfei@acblock-lab.com China 10035 58
PharmaBlock Sciences (Nanjing), Inc. 4000255188 4000255188
 sales@pharmablock.com China 7268 58
Nantong Hanfang Biotechnology Co. , Ltd. 18616537568
 hanfangpharma@126.com China 30961 58
  • Cyclobutanemethanamine, 3-phenyl-, hydrochloride (1:1)
  • (3-phenylcyclobutyl)methanamine hydrochloride
  • 1-(3-phenylcyclobutyl)methanamine hydrochloride
  • 1803611-35-9
Copyright 2019 ? ChemicalBook. All rights reserved